Free Trial

Xeris Biopharma (XERS) Institutional Ownership

Xeris Biopharma logo
$5.00 -0.09 (-1.67%)
As of 12:46 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Institutional Ownership Changes (13F Filings) for Xeris Biopharma (NASDAQ:XERS)

Current
Institutional Ownership
Percentage
42.75%
Number of
Institutional Buyers
(last 12 months)
100
Total
Institutional Inflows
(last 12 months)
$105.68M
Number of
Institutional Sellers
(last 12 months)
37
Total
Institutional Outflows
(last 12 months)
$29.54M
Get XERS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Xeris Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

XERS Institutional Buying and Selling by Quarter

Xeris Biopharma Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/16/2025 Caxton Associates LLP30,938$170K0.0%N/A0.020%
5/16/2025 Fred Alger Management LLC134,016$736K0.0%N/A0.086%
5/16/2025 Goldman Sachs Group Inc.2,790,014$15.32M0.0%+75.4%1.784%
5/16/2025 Parkman Healthcare Partners LLC1,780,454$9.78M1.2%+207.8%1.139%
5/16/2025 Millennium Management LLC2,317,972$12.73M0.0%+19.0%1.482%
5/16/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.83,982$461K0.0%+4.5%0.054%
5/16/2025 Jacobs Levy Equity Management Inc.255,560$1.40M0.0%N/A0.163%
5/16/2025 Bosun Asset Management LLC85,111$467K0.2%N/A0.054%
5/16/2025 AQR Capital Management LLC946,766$5.20M0.0%+13.4%0.605%
5/15/2025 PDT Partners LLC239,600$1.32M0.1%N/A0.153%
5/15/2025 Cubist Systematic Strategies LLC811,607$4.46M0.0%N/A0.519%
5/15/2025 Royal Bank of Canada213,084$1.17M0.0%+1,411.2%0.136%
5/15/2025 Graham Capital Management L.P.133,668$734K0.0%+89.2%0.085%
5/15/2025 Alpine Global Management LLC100,000$549K0.1%-37.5%0.064%
5/15/2025 Quarry LP70,751$388K0.1%N/A0.045%
5/15/2025 Driehaus Capital Management LLC1,411,540$7.75M0.1%+137.6%0.903%
5/15/2025 Landscape Capital Management L.L.C.15,709$86K0.0%N/A0.010%
5/14/2025 Ieq Capital LLC155,184$852K0.0%+129.2%0.099%
5/14/2025 Rafferty Asset Management LLC15,003$82K0.0%-15.3%0.010%
5/14/2025 FORA Capital LLC11,017$60K0.0%N/A0.007%
5/14/2025 MetLife Investment Management LLC81,769$449K0.0%-6.5%0.052%
5/14/2025 Stonepine Capital Management LLC102,265$561K0.5%-43.9%0.065%
5/14/2025 Walleye Capital LLC691,719$3.80M0.0%N/A0.442%
5/14/2025 Jump Financial LLC423,523$2.33M0.0%+1,371.4%0.271%
5/14/2025 EntryPoint Capital LLC75,706$416K0.2%+43.5%0.048%
5/14/2025 Voss Capital LP275,000$1.51M0.1%N/A0.176%
5/14/2025 Quantbot Technologies LP54,107$297K0.0%N/A0.035%
5/14/2025 Wellington Management Group LLP392,099$2.15M0.0%-15.7%0.251%
5/13/2025 Russell Investments Group Ltd.131,687$723K0.0%+632.7%0.084%
5/13/2025 Informed Momentum Co LLC934,646$5.13M0.9%+320.3%0.598%
5/12/2025 Knott David M Jr1,110,000$6.09M2.9%+11.0%0.710%
5/12/2025 Nuveen LLC2,229,507$12.24M0.0%N/A1.426%
5/12/2025 Aigen Investment Management LP16,769$92K0.0%N/A0.011%
5/12/2025 Invesco Ltd.1,026,838$5.64M0.0%+1,387.8%0.657%
5/12/2025 Connor Clark & Lunn Investment Management Ltd.589,471$3.24M0.0%+244.1%0.377%
5/9/2025 CenterBook Partners LP472,075$2.59M0.2%-31.6%0.302%
5/9/2025 Deutsche Bank AG756,407$4.15M0.0%+492.8%0.484%
5/9/2025 Charles Schwab Investment Management Inc.423,775$2.33M0.0%+5.2%0.271%
5/9/2025 Vanguard Group Inc.8,109,644$44.52M0.0%+2.7%5.186%
5/9/2025 R Squared Ltd15,730$86K0.1%+27.7%0.010%
The MAGA 7 Stocks: Huge Upside in 2025 (Ad)

The Trump economy is back in full force, and it’s creating huge opportunities for investors. With Trump pushing for lower taxes, fewer regulations, tariffs on foreign competitors, and domestic manufacturing dominance, some stocks are set to skyrocket in value—while others will be left behind. That’s why we put together this free report revealing the 7 MAGA stocks poised to thrive in 2025.

🔻 Download the full report now and get the inside track on these 7 powerhouse stocks.
5/8/2025 XTX Topco Ltd216,228$1.19M0.1%N/A0.138%
5/8/2025 GSA Capital Partners LLP138,735$762K0.1%+178.3%0.089%
5/8/2025 Federated Hermes Inc.687,783$3.78M0.0%+36,542.7%0.440%
5/7/2025 Essex Investment Management Co. LLC730,444$4.01M0.8%+53.8%0.467%
5/7/2025 Mackenzie Financial Corp142,104$780K0.0%+9.4%0.091%
5/6/2025 Cetera Investment Advisers44,597$245K0.0%N/A0.029%
5/6/2025 Legato Capital Management LLC217,318$1.19M0.2%+52.9%0.139%
5/6/2025 Y Intercept Hong Kong Ltd44,518$244K0.0%N/A0.028%
5/2/2025 Apollon Wealth Management LLC24,160$133K0.0%+19.8%0.015%
5/2/2025 Sigma Planning Corp73,950$406K0.0%-3.9%0.047%
5/1/2025 CWM LLC66,972$368K0.0%+79.3%0.043%
5/1/2025 New York State Common Retirement Fund43,422$238K0.0%+90.3%0.028%
5/1/2025 Gateway Wealth Partners LLC16,800$92K0.0%N/A0.011%
5/1/2025 Xponance Inc.10,319$57K0.0%N/A0.007%
4/30/2025 Cerity Partners LLC31,851$175K0.0%+107.3%0.020%
4/30/2025 Brown Advisory Inc.114,698$630K0.0%-39.7%0.073%
4/29/2025 Bank of New York Mellon Corp360,324$1.98M0.0%+11.8%0.230%
4/17/2025 FNY Investment Advisers LLC11,500$63K0.0%N/A0.007%
4/16/2025 Wealth Enhancement Advisory Services LLC31,254$172K0.0%+92.1%0.020%
4/15/2025 SG Americas Securities LLC70,499$387K0.0%-25.5%0.046%
4/14/2025 Pallas Capital Advisors LLC15,343$84K0.0%N/A0.010%
4/10/2025 Apella Capital LLC10,000$55K0.0%N/A0.006%
4/8/2025 Rhumbline Advisers192,281$1.06M0.0%+6.3%0.125%
3/24/2025 Wellington Management Group LLP465,112$1.58M0.0%-1.4%0.302%
3/17/2025 Wealth Enhancement Advisory Services LLC16,268$55K0.0%+31.0%0.011%
2/20/2025 Mackenzie Financial Corp129,952$441K0.0%+446.0%0.087%
2/17/2025 Squarepoint Ops LLC40,769$138K0.0%+118.2%0.027%
2/17/2025 Two Sigma Advisers LP13,741$47K0.0%N/A0.009%
2/17/2025 Stonepine Capital Management LLC182,317$618K0.5%N/A0.122%
2/17/2025 Sherbrooke Park Advisers LLC23,326$79K0.0%N/A0.016%
2/17/2025 Redmile Group LLC451,099$1.53M0.1%-56.9%0.303%
2/17/2025 ProShare Advisors LLC46,553$158K0.0%-34.1%0.031%
2/17/2025 Parkman Healthcare Partners LLC578,511$1.96M0.3%+465.0%0.388%
2/17/2025Nuveen Asset Management LLC1,903,442$6.45M0.0%+13.6%1.277%
2/17/2025 Occudo Quantitative Strategies LP51,737$175K0.0%+57.8%0.035%
2/17/2025 Millennium Management LLC1,948,552$6.61M0.0%+34.8%1.307%
2/17/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.80,388$273K0.0%+4.5%0.054%
2/17/2025 Graham Capital Management L.P.70,662$240K0.0%+32.2%0.047%
2/17/2025 Fairfax Financial Holdings Ltd. Can139,687$472K0.0%-18.3%0.094%
2/17/2025 Deutsche Bank AG127,600$433K0.0%+60.4%0.086%
2/17/2025 D. E. Shaw & Co. Inc.1,363,452$4.62M0.0%+38.4%0.915%
2/17/2025 Driehaus Capital Management LLC594,015$2.01M0.0%N/A0.398%
2/17/2025 Caxton Corp2,015,157$6.83M41.1%-60.6%1.352%
2/17/2025 Balyasny Asset Management L.P.17,153$58K0.0%N/A0.012%
2/17/2025 Bank of America Corp DE991,657$3.36M0.0%-1.7%0.665%
2/17/2025 BNP Paribas Financial Markets100,012$339K0.0%N/A0.067%
2/17/2025 Ameriprise Financial Inc.209,923$712K0.0%-3.3%0.141%
2/14/2025 Jane Street Group LLC306,245$1.04M0.0%-3.9%0.205%
2/14/2025 Schonfeld Strategic Advisors LLC103,000$349K0.0%-40.2%0.069%
2/14/2025 Northern Trust Corp1,196,381$4.06M0.0%+3.3%0.803%
How Trade Wars Are Creating Fresh Opportunities for Investors (Ad)

Tariffs and trade tensions are back in the headlines, and while many are focused on the risks, smart investors know there’s also opportunity. New supply chain shifts, pricing power adjustments, and sector revaluations are already underway—creating openings for those who act early. That’s why we’ve just released our latest research: 📈 “From Tariffs to Returns: How to Capitalize on Trade Disputes in Your Portfolio”

Position yourself ahead of the next move—get the full report here.
2/14/2025 The Manufacturers Life Insurance Company53,053$180K0.0%-5.5%0.036%
2/14/2025 Tudor Investment Corp ET AL305,186$1.04M0.0%-39.8%0.205%
2/14/2025 Aquatic Capital Management LLC14,684$50K0.0%N/A0.010%
2/14/2025 Susquehanna Fundamental Investments LLC19,712$67K0.0%N/A0.013%
2/14/2025 Virtus ETF Advisers LLC20,910$71K0.0%N/A0.014%
2/14/2025 Voya Investment Management LLC44,753$152K0.0%-7.5%0.030%
2/14/2025 Price T Rowe Associates Inc. MD170,482$578K0.0%+5.9%0.114%
2/14/2025 Hsbc Holdings PLC16,312$56K0.0%-31.1%0.011%
2/14/2025 IHT Wealth Management LLC270,160$916K0.0%-2.4%0.181%
2/14/2025 MetLife Investment Management LLC87,432$296K0.0%+47.7%0.059%
(Data available from 1/1/2016 forward)

XERS Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of XERS shares?

During the previous two years, 143 institutional investors and hedge funds held shares of Xeris Biopharma. The most heavily invested institutionals were Vanguard Group Inc. ($44.52M), Goldman Sachs Group Inc. ($15.32M), Millennium Management LLC ($12.73M), Nuveen LLC ($12.24M), Geode Capital Management LLC ($11.36M), Parkman Healthcare Partners LLC ($9.78M), and State Street Corp ($9.13M).Learn more on XERS's institutional investors.

What percentage of Xeris Biopharma stock is owned by institutional investors?

42.75% of Xeris Biopharma stock is owned by institutional investors. Learn more on XERS's institutional investor holdings.

Which institutional investors have been buying Xeris Biopharma stock?

Of the 117 institutional investors that purchased Xeris Biopharma stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Nuveen LLC ($2.23M), Walleye Capital LLC ($1.81M), Parkman Healthcare Partners LLC ($1.68M), Driehaus Capital Management LLC ($1.41M), Goldman Sachs Group Inc. ($1.20M), Invesco Ltd. ($957.82K), and Millennium Management LLC ($872.27K).

How much institutional buying is happening at Xeris Biopharma?

Institutional investors have bought a total of 26,571,626 shares in the last 24 months. This purchase volume represents approximately $113.58M in transactions.

Which Xeris Biopharma major shareholders have been selling company stock?

Of the 40 institutional investors that sold Xeris Biopharma stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Caxton Corp ($3.50M), CenterBook Partners LP ($3.01M), Rosalind Advisors Inc. ($738.69K), Deltec Asset Management LLC ($608.07K), Redmile Group LLC ($595.49K), GSA Capital Partners LLP ($578.31K), and XTX Topco Ltd ($241.16K).

How much institutional selling is happening at Xeris Biopharma?

Institutional investors have sold a total of 10,517,587 shares in the last 24 months. This volume of shares sold represents approximately $34.00M in transactions.



This page (NASDAQ:XERS) was last updated on 5/21/2025 by MarketBeat.com Staff
From Our Partners